Research Article
Antifungal Susceptibility Patterns of Candida Species Recovered from Endotracheal Tube in an Intensive Care Unit
Table 2
MIC interpretation of five antifungal drugs against Candida spp. recovered from endotracheal tube.
| Antifungal agents | C. albicans (%) | C. glabrata (%) | C. parapsilosis (%) | C. tropicalis (%) | C. krusei (%) |
| Amphotericin B | S | 28 (82.3) | 20 (83.3) | 16 (100) | 10 (83.3) | 7 (77.7) | R | 6 (17.6) | 4 (16.6) | — | 2 (16.7) | 2 (22.2) |
| Itraconazole | S | 20 (58.8) | 12 (50) | 6 (37.5) | 4 (33.3) | 3 (33.3) | DD | 2 (5.8) | 6 (25) | 10 (62.5) | — | 5 (55.5) | R | 12 (35.2) | 6 (25) | — | 8 (66.6) | 1 (11.1) |
| Voriconazole | S | 27 (79.4) | 11 (45.8) | 12 (75) | 4 (33.3) | 6 (66.6) | DD | 2 (5.8) | 5 (20.8) | 4 (25) | 3 (25) | 2 (22.2) | R | 5 (14.7) | 8 (33.3) | — | 5 (41.6) | 1 (11.1) |
| Fluconazole | S | 22 (64.7) | 3 (12.5) | 14 (87.5) | 3 (25) | 5 (55.5) | DD | 3 (8.8) | 2 (8.3) | 2 (12.5) | 4 (33.3) | 2 (22.2) | R | 9 (26.4) | 19 (79.1) | — | 5 (41.6) | 2 (22.2) |
| Caspofungin | S | 34 (100) | 24 (100) | 16 (100) | 12 (100) | 9 (100) | R | — | — | — | — | — |
|
|
S: susceptible; R: resistance; DD: dose-dependent.
|